Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer
Authors
Keywords
Bladder cancer, microRNA-96, CDKN1A, Proliferation, Apoptosis
Journal
Cancer Cell International
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-11-14
DOI
10.1186/s12935-015-0235-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy
- (2015) Guofeng Cheng ADVANCED DRUG DELIVERY REVIEWS
- Emerging therapeutic targets in bladder cancer
- (2015) Benedito A. Carneiro et al. CANCER TREATMENT REVIEWS
- World Urologic Oncology Federation Bladder Cancer Prevention Program: A global initiative
- (2015) Laurence Klotz et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Loss of p21Cip1/CDKN1A renders cancer cells susceptible to Polo-like kinase 1 inhibition
- (2015) Nina-Naomi Kreis et al. Oncotarget
- HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96
- (2015) Jin Feng et al. Oncotarget
- MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancer
- (2014) Haifeng Xia et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNAome genome: A treasure for cancer diagnosis and therapy
- (2014) Ioana Berindan-Neagoe et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression
- (2014) Shakir M. Saud et al. CARCINOGENESIS
- BAX and CDKN1A polymorphisms correlated with clinical outcomes of gastric cancer patients treated with postoperative chemotherapy
- (2014) Xiaoting Wang et al. MEDICAL ONCOLOGY
- miR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells
- (2014) Haizhou Guo et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- miR-375 activates p21 and suppresses telomerase activity by coordinately regulating HPV E6/E7, E6AP, CIP2A, and 14-3-3ζ
- (2014) Hyun Jung et al. Molecular Cancer
- Combined CDKN1A/TP53 Mutation in Bladder Cancer Is a Therapeutic Target
- (2014) Y. Liu et al. MOLECULAR CANCER THERAPEUTICS
- LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression
- (2014) S Bianco et al. ONCOGENE
- Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer
- (2014) Juan Li et al. TUMOR BIOLOGY
- Erratum: Corrigendum: Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden
- (2014) J. -B. Cazier et al. Nature Communications
- Regulation of MicroRNAs by Natural Agents: New Strategies in Cancer Therapies
- (2014) Neoh Hun Phuah et al. Biomed Research International
- MicroRNA-31 Activates the RAS Pathway and Functions as an Oncogenic MicroRNA in Human Colorectal Cancer by Repressing RAS p21 GTPase Activating Protein 1 (RASA1)
- (2013) Defang Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aberrant expression of microRNAs in bladder cancer
- (2013) Hirofumi Yoshino et al. Nature Reviews Urology
- miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions
- (2013) Sheng-Da Hsu et al. NUCLEIC ACIDS RESEARCH
- The role of p21waf1/cip1 and p27Kip1 in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma
- (2013) A Newbold et al. ONCOGENE
- MicroRNA-23b Functions as a Tumor Suppressor by Regulating Zeb1 in Bladder Cancer
- (2013) Shahana Majid et al. PLoS One
- miR-143, miR-222, and miR-452 Are Useful as Tumor Stratification and Noninvasive Diagnostic Biomarkers for Bladder Cancer
- (2012) Patricia Puerta-Gil et al. AMERICAN JOURNAL OF PATHOLOGY
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MiR-96 Downregulates REV1 and RAD51 to Promote Cellular Sensitivity to Cisplatin and PARP Inhibition
- (2012) Yemin Wang et al. CANCER RESEARCH
- MiR-663, a microRNA targeting p21 WAF1/CIP1 , promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma
- (2012) C Yi et al. ONCOGENE
- Synthetic miRNA-Mowers Targeting miR-183-96-182 Cluster or miR-210 Inhibit Growth and Migration and Induce Apoptosis in Bladder Cancer Cells
- (2012) Yuchen Liu et al. PLoS One
- miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer
- (2010) S. Yu et al. CANCER RESEARCH
- Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor
- (2009) Miguel F. Segura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors
- (2008) K P Jensen et al. MOLECULAR PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started